Skip to main content
Fig. 5 | BMC Cancer

Fig. 5

From: Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene

Fig. 5

RNAseq and gene set enrichment analysis (GHSEA) results for PGAP3-SRPK1 fusion knockdown. A) qPCR of MD8788–6 treated with PGAP3-SRPK1 siRNA compared to NT siRNA. Results are quantified as log2 fold change of NT siRNA samples. Results demonstrate knockdown of PGAP3/SRPK1 mRNA without changes in WT SRPK1 expression and confirm RNAseq results showing decreases in HSDL2 and CCDN1 and a small increase in FOXO4 with PGAP3-SRPK1 knockdown (n = 2 replicates). B) GSEA results demonstrating a negative correlation with KOBAYASHI_EGFR_SIGNALING_24HR_DN, HALLMARK_E2F_TARGETS, and HALLMARK_MYC_TARGETS_V1 pathways in samples with PGAP3-SRPK1 knockdown

Back to article page